Welcome to the 184th Pari Passu newsletter.
Rinchem is a name that most people outside of specialty logistics have never heard, but the company sits at the center of one of the world's most critical supply chains. Founded in 1976, Rinchem has grown into the operator of the world’s largest network of hazardous chemical and gas distribution centers, serving numerous Fortune 500 customers. In early 2022, private equity firm Stonepeak acquired Rinchem, betting on secular tailwinds from domestic semiconductor expansion. Instead, an array of end-market issues and a capital structure that left no margin for error collided and pushed the company into distress within three years of the buyout.
In January 2026, Rinchem announced a transaction that combined a merger with another Stonepeak portfolio company, Dupré Logistics, with a discounted exchange and a $100mm new-money raise. The deal, which unfolded over eight months of negotiations, featured the interplay of many modern LME dynamics, including some we’ve written about as well as entirely new ones.
In today's writeup, we'll start by overviewing Rinchem's specialized business model and the barriers to entry that shape its competitive position. From there, we'll trace its corporate history from a small Albuquerque distributor through its international expansion and eventual sale to Stonepeak. We'll then walk through the path to distress, driven by freight market normalization, semiconductor weakness, and a customer concentration problem that proved to be the single biggest factor. We’ll end by breaking down the 2026 LME, its negotiation dynamics, and what the transaction means moving forward.
A preview of 9fin research
9fin just raised $170mm to further scale their platform, which centralizes institutional-grade data, legal analysis, and news across the debt markets (see an example below).
It’s how top-tier teams stay ahead of the next LME or restructuring. To see how their intelligence can sharpen your firm’s edge, you can claim a 45-day trial here

Business Model
Rinchem is a specialty logistics provider for hazardous chemicals and high-purity gases, one of the most tightly regulated supply chains. The company warehouses and transports the volatile materials used in semiconductors, pharmaceuticals, and aerospace components. To understand why Rinchem exists, it's important to understand why its customers can't just use a normal logistics provider. For example, semiconductor fabrication, Rinchem’s largest end market, requires ultra-high-purity chemicals that must be stored in temperature-controlled environments, segregated by chemical compatibility class, and transported in hazmat-certified vehicles. A standard third-party logistics provider almost never operates the advanced warehouses and vehicles required for hazardous materials due to the associated capital and regulatory requirements.
Rinchem breaks its revenue into warehousing and transportation. The warehousing segment, which is the more stable of the two, operates under long-term contracts with blue-chip customers, such as Fortune 500 semiconductor fabricators, pharmaceutical manufacturers, and defense contractors. Inherently, customer relationships are extremely sticky. Switching costs become very high once a customer has integrated with Rinchem’s highly regulated facilities and inventory management software. The transportation segment, which includes over-the-road trucking, local delivery, and international freight forwarding, is more cyclical, as we’ll learn later.

Figure 1: Rinchem’s hazmat platform combines warehousing and transportation
As of early 2026, Rinchem operates 31 specialized distribution centers across six countries: the United States, Ireland, Israel, Malaysia, South Korea, and Taiwan. These facilities total roughly 1.4mm square feet of warehouse space, equivalent to roughly 24 football fields. Annually, Rinchem handles over 4bn pounds of materials, enough to fill roughly 300,000 semi-trucks each year. Rinchem’s business model is very capital-intensive, as the company builds and maintains its own hazmat infrastructure, including temperature-controlled warehouses, regulatory-compliant storage systems, and a fleet of hazmat-certified vehicles. Rinchem recently completed a major buildout of three new facilities to support semiconductor fabricators expanding domestic production under the CHIPS Act. As a reminder, the CHIPS Act was signed into law in 2022 and subsidizes domestic semiconductor manufacturing. Importantly, some of this capital spending is tied to contractual agreements with customers, which means Rinchem can’t just pause new projects if market conditions deteriorate.
Another important consideration for Rinchem is its customer and end-market concentration. Nearly half of total sales come from a single major customer, and the company’s top ten customers account for roughly 75% of revenue. In terms of end markets, the semiconductor and electronics industry has historically accounted for roughly 76% of revenue. While these customer relationships are strong, this concentration means Rinchem’s financial health is essentially tied to the semiconductor production cycle. When chip production is at healthy levels, Rinchem is able to keep warehouses full and trucks moving. However, if production slows, not only does utilization and operating profit fall, but Rinchem’s contractual capital spending can cause an even greater cash deficit.
Corporate History
Rinchem was founded in 1976 by Bill Moore, who established a small chemicals distribution center in Albuquerque, New Mexico, as a second location for an Arizona-based distributor. Moore initially ran a two-person operation that supplied general chemicals to local industries, including paint and fiberglass manufacturers [2]. In 1983, Moore purchased the Albuquerque location himself, and that same year landed a pivotal contract to store and continuously replenish specialty chemicals for a large semiconductor manufacturer, a relationship that would go on to shape the company's trajectory.
Over the next two decades, Rinchem evolved from a regional chemical distributor into a dedicated third-party logistics provider for the semiconductor supply chain. By 2000, the company had more than $10mm in revenue [3]. The following year, in 2001, Rinchem made the strategic decision to exit general chemical distribution entirely and focus solely on third-party logistics (3PL) services, including warehousing, transportation, and supply chain management for hazardous materials [3]. To briefly clarify, a chemical distributor purchases chemicals, stores them, and sells them later, adding inventory and commodity price risk. A 3PL provider, on the other hand, stores and transports customers’ chemicals, earning revenue from contractual fees, rather than margins on chemical sales. This pivot allowed Rinchem to build a more stable, recurring revenue base. By 2005, Rinchem had begun expanding internationally, opening warehouses near semiconductor fabricators in Asia to serve the industry’s increasingly global footprint. It was also during this period that Rinchem added Chem-Star, its inventory management platform.
During the 2010s, Rinchem underwent aggressive inorganic growth via a series of transactions to expand both geographic reach and capabilities. These acquisitions included that of Chimei Logistics in Taiwan (2014), IHUB in South Korea (2015), JS Transportation in Taiwan (2017), and Carolina Tank Lines in North Carolina (2019) [1]. The Chimei and JS acquisitions gave Rinchem the largest market share for specialty gas transportation in Taiwan, while the purchase of Carolina Tank Lines helped the company diversify into pharmaceutical logistics. By the end of the decade, Rinchem operated more than 300 semi-trucks (tractor units with the engine and cab) and 400 specialized trailers (the attached units designed to transport hazardous materials).
The early 2020s marked the beginning of a boom in domestic semiconductor manufacturing driven by pandemic-era supply chain disruptions, rising geopolitical tensions, and surging demand for compute. Governments, including the United States through the CHIPS Act, began aggressively subsidizing domestic chip production, driving a rapid wave of investment that Rinchem directly benefited from. For example, in August 2021, Rinchem announced a significant partnership with one of the world’s largest semiconductor manufacturers (think TSMC, Intel, Samsung, etc.) [4]. As the manufacturer opened a new Arizona facility, Rinchem partnered with it to handle its entire chemical supply chain, agreeing to break ground on a warehousing facility of its own in 2022, highlighting an important example of the contractual capital spend we mentioned in the business model section above.
While Rinchem did not name the customer, the press release's language, describing a manufacturer "entering the US semiconductor market" and expanding its "global footprint here in the United States," is telling. Intel has been manufacturing in Arizona for decades and would not be described as "entering" the domestic market. Samsung, the other plausible candidate at that scale, ultimately chose Texas for its US fab expansion. That leaves TSMC, which had announced its first advanced-node US fab in Phoenix in 2020, with construction ramping in 2021, which aligns almost exactly with Rinchem's announcement. Commercial real estate reporting from the period further supports this, stating that Rinchem selected its Surprise, Arizona site specifically for its proximity to the TSMC plant in north Phoenix. While we cannot confirm this definitively, the weight of evidence suggests TSMC was the partner behind the 2021 announcement.
Throughout its entire history, up to this point, Rinchem remained family-owned. However, amidst this production boom, the company became an attractive target for institutional capital. In January 2022, Stonepeak, a New York-based PE firm, announced its acquisition of Rinchem. In Stonepeak’s press release, the firm framed the deal around the secular tailwinds in specialty logistics, the company’s blue-chip customer base, and the anticipated wave of domestic semiconductor manufacturing [5]. Under early Stonepeak ownership, Rinchem continued its capex-heavy buildout, opening facilities in Oregon and Malaysia, as well as the new Arizona facility, primarily to support semiconductor production capacity.
Path to Distress
Stonepeak funded the deal with a $300mm term loan B due 2029 and a $35mm RCF due 2027. While financial terms were not revealed, subsequent disclosures indicate a $660mm equity check for a total transaction value in the mid $900mm range [17]. At close, S&P reported leverage of approximately 6.5x, implying roughly $46mm of adj. EBITDA [6]. Given our valuation estimate of $935mm, this corresponds to an LTV of roughly 32% and an approximate entry multiple of 20x. This relatively conservative leverage profile is consistent with the company’s capital-intensive operations and strong exposure to cyclical end markets. However, even with modest leverage, a business with customer concentration, high fixed costs, and cyclical demand remains highly sensitive to earnings declines, leaving limited margin for error if volumes deteriorate.

Figure 2: 2022 Stonepeak Buyout
The first crack appeared in Rinchem’s freight forwarding segment. Freight forwarders are essentially the “travel agents” of cargo, booking cargo space, planning routes, and handling documentation. Rinchem primarily forwarded for international ocean-based shipping, as the company did not own its own cargo ships. For Rinchem, this sub-segment is less structurally attractive than its core hazmat 3PL operations. Unlike its owned fleet and specialized warehouse network, freight forwarding has lower barriers to entry and greater competition from global logistics providers. Therefore, the segment tends to generate lower margins and less sticky, more transactional revenue, making it more sensitive to volume fluctuations and pricing pressure. This manifested itself in 2023, when ocean container shipping rates fell from pandemic-era levels. In 2021 and 2022, Rinchem’s forwarding business benefited from elevated transportation costs, but as that market corrected, the freight forwarding segment’s contribution to Rinchem’s EBITDA declined significantly, reducing the earnings base supporting the buyout’s debt load [6].
In addition to freight-forwarding issues, the semiconductor industry entered a prolonged inventory correction in 2023. During the 2021-2022 boom, when international supply chains remained uncertain, domestic chip production drove record demand for chip supplies and, by extension, for Rinchem’s services. However, as uncertainties subsided, Chip producers began working through the excess inventory accumulated in the years prior. However, the industry-wide slowdown only tells part of the story. As we noted in the business model section, nearly half of Rinchem’s revenue came from a single major customer, an abnormally high level of concentration. When that customer entered its own operational restructuring process, the impact on Rinchem was extreme. The customer's restructuring likely resulted in reduced chemical procurement, pulling volume out of Rinchem's warehouses that had been built or expanded to serve that relationship.
While Rinchem has not publicly disclosed its largest customer, available evidence points to Intel. A third-party logistics industry profile identifies Rinchem as a chemical logistics supplier to Intel and names Intel as the company's largest customer, while Intel's own corporate responsibility reporting lists Rinchem among its top 100 production and service suppliers by spend [14], [15]. Intel also fits quite strongly with the reported distress timeline. In August 2024, Intel announced a sweeping cost reduction program that included approximately 15,000 job cuts, and the company's SEC filings detail a formal 2024 Restructuring Plan with associated charges. Intel also delayed its Ohio megaproject and pulled back on capital spending across multiple sites, which would clearly reduce chemical procurement volumes at a logistics partner like Rinchem.
Compounding the issues above, with revenues declining, Rinchem couldn’t slow down capital spending to match. As we noted above, several of the company’s major facility buildouts were tied to contractual commitments with semiconductor customers investing in new fabs. Rinchem was obligated to complete these projects regardless of whether current demand justified the capex. Additionally, the Fed’s rate-hiking cycle caused Rinchem’s interest expense to balloon. As SOFR increased from near-zero in early 2022 to more than 5% by mid-2023, annual interest expense on Rinchem’s $300mm 1L TL, which was priced at S + 4.50%, more than doubled from $14mm to $29mm, consuming a significant amount of EBITDA, even when applied to 2022 EBITDA of $46mm.
By the end of 2023, S&P estimated that leverage had increased to mid 9x levels, implying $33mm of EBITDA, or a 28% decrease from post-buyout levels. This decline in EBITDA, combined with a rising interest burden and sustained capex, resulted in $30-35mm of cash burn in 2023 [8]. To account for this deficit, from Q4 2022 to Q4 2024, Rinchem drew down nearly all of its RCF, leaving just $4mm of availability at the end of 2023 [8]. Assuming a minimum cash balance of $5mm, Rinchem entered 2024 with less than $10mm of liquidity, coming off a year in which the company had just burned more than $30mm of cash.
With no sign of near-term rate cuts, a drop in capex, or a significant operational rebound, Rinchem was in desperate need of liquidity support in early 2024. Rather than approach lenders, Stonepeak itself injected a $45mm incremental first-lien PIK loan, priced at S + 4.50%, to repay the $31mm drawn on the RCF and provide additional liquidity support [8]. While the sponsor PIK loan provided short-term liquidity relief, 2024 volumes would have to rebound significantly for Rinchem to avoid a repeat of this situation.
Unfortunately, the hoped-for 2024 recovery never materialized. As 2024 demand partially rebounded, it still remained soft relative to what drove the company’s contractual buildouts, and Rinchem struggled to fill its new Malaysia and Oregon warehouses, meaning operating leverage continued to work against the company. By May 2024, Rinchem was already applying another liquidity band-aid, as it executed a sale-leaseback transaction on its Taiwan operations, generating approximately $35mm to once again repay its RCF, which it had drawn amidst continued cash burn in H1 2024 [9]. While the sale-leaseback restored liquidity, maneuvers like that are one-time in nature, as they consume limited unencumbered assets. Following this transaction, a pattern was becoming familiar in which liquidity would deteriorate, the company would find a creative way to free up revolver capacity, and the clock would reset. However, each temporary solution would leave fewer options remaining, as the PIK loan added debt and the sale-leaseback consumed an unencumbered asset. The revolver itself was a finite resource with a March 2027 maturity that was drawing closer each time this occurred.
Just like the year before, Rinchem entered 2025 hoping for a rebound that never took place. 2025 adj. EBITDA remained at just $31mm amidst continued demand headwinds and an oversized cost structure. This was barely enough to cover interest expense, which remained in the high $20mm range. Additionally, continued capital spend requirements materialized in a $14mm free cash flow deficit over the first 9 months of 2025 (~$20mm annualized), with deficits projected through the remainder of 2025 and 2026 [10].
Rather than search for another short-term liquidity bridge, in May 2025, Rinchem began exploring a more comprehensive restructuring, retaining Houlihan Lokey and Paul Weiss. Around the same time, a majority creditor group organized with Solomon Partners and Paul Hastings, while a minority lender group retained Glenn Agre. Rinchem negotiated with lenders over the next couple of months, but by July, the conversations stalled without producing a deal [11]. Rinchem then disclosed to private investors that it had designated certain subsidiaries as unrestricted [11]. As a reminder, an unrestricted subsidiary (UnSub) sits outside the restricted credit group and is not bound by the overarching credit agreement. This designation is effectively interpreted as a precursor to execute a deal-away transaction that could strip assets beyond the reach of existing creditors, potentially raising new money from a third party. Upon news of these designations, Rinchem’s term loan dropped to the mid 50s, down from the 70s a couple of months prior. By late 2025, Rinchem’s term loan traded in the low 40s, a deeply distressed level for first-lien debt, reflecting the market’s uncertainty around potential recoveries. Moreover, this price implied approximately $120mm of enterprise value, down nearly 90% from the 2022 buyout. This valued Rinchem at roughly 4x 2025 EBITDA of $31mm, a valuation indicating clear distress.
Lastly, before we move to the 2026 LME, it’s important to cover an adjacent development that played a role in the upcoming transaction. In April 2025, Stonepeak acquired a majority stake in Dupré Logistics, a Lafayette, Louisiana-based transportation company with a fleet of over 700 trucks, 1,000 drivers, and partnerships with more than 16,000 carriers [12]. Dupré specializes in energy distribution, private fleet services, and capacity brokerage across the Gulf Coast and broader U.S., representing a complementary but distinct business from Rinchem's. Notably, Stonepeak installed Rinchem's COO, Chris Sower, as Dupré's interim CEO, signaling a potential combination of the two portfolio companies, which leads us into the 2026 transaction.
The 2026 LME
On January 28, 2026, Rinchem announced a transaction that included both a merger and a liability management exercise.
You are about to reach the midpoint of the report. This is where the story gets interesting.
Free readers miss out on the sections that explain:
• LME Breakdown and Exact Economics
• The Dupré Merger
• Transaction Analysis
• Key Takeaways
Upgrade to Pari Passu Premium to access the remainder of this deep-dive, the full archive with over 150 editions, and our restructuring drive.
As a reminder, most firms (including Pods) pay for Pari Passu Premium. You can find an email template to send them here, and feel free to email us if we can help in any way.
Retail Opportunity from Lightstone Capital

Many of you have asked about the Lightstone Group
This is an example of the email with the investment opportunities that you are provided after registering:
Summary of the opportunity
50-page deck with detailed underwriting details
Ability to discuss the deal live with a member of the Lightstone Group
Accredited Investors can join at no cost here.
Unlock the Full Analysis and Proprietary Insights
A Pari Passu Premium subscription provides unrestricted access to this report and our comprehensive library of institutional-grade research
Upgrade NowA subscription gets you:
- Institutional Level Coverage of Restructuring Deals
- Full Access to Our Entire Archive
- 150+ Reports of Evergreen Research
- Full Access to All New Research
- Access to the Restructuring Drive
- Join Thousands of Professional Readers
